Gilead Sciences announced its Phase 3 PURPOSE 1 trial results showing 100% efficacy of twice-yearly injectable lenacapavir in preventing HIV-1 in cisgender women. The trial met key efficacy endpoints, demonstrating superiority over daily Truvada and background HIV incidence.
Commercial Metals reported third-quarter results with net sales of $2.078 billion. Europe Steel Group saw improved performance. Available liquidity at $1.5 billion. Quarterly dividend of $0.18 announced. Expecting consistent results in Q4.
Pantera Capital is contemplating a substantial investment of up to $100 million in Bitwise's spot Ethereum (CRYPTO: ETH) ETF, pending regulatory approval for the fu
Bank of England kept rates steady while Swiss National Bank cut its key rate. UK ETFs ticked up, with EWU up 0.66%, FLGB up 0.7%, and FKU up 0.57%. BOE is expected to cut rates in August, while other European central banks have already begun easing.
Roger Stone, a long-time friend and former political advisor to Donald Trump, has officially denied any involvement of the former president or his son, Barron, in the (CRYPTO: DJT) Solana (CRYPTO: SOL